The Duchenne muscular dystrophy (DMD) market is projected to grow from $2.3 billion in 2023 to $5.2 billion in 2033 across ...
The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, ...
Pratteln, Switzerland Friday, February 14, 2025, 15:00 Hrs [IST] ...
The Swiss biopharma company said the deal with the German National Association of Statutory Health Insurance Funds (GKV-SV) ...
Santhera Pharmaceuticals, a Swiss specialty pharma focused on rare diseases, has announced an agreement with the German National Association of Statutory Health Insurance Funds (GKV-SV) on the ...
NORBIT delivered record-high revenues of NOK 1,751.4 million for the financial year 2024, with an operating profit (EBIT) for the full-year period at NOK 341.7 million, representing a margin of 20 per ...
Catherine Isted, an experienced healthcare CFO with over 25 years in life sciences, appointed as CFO effective February 24, 2025Current CFO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results